scholarly journals Effects of Different Levels of Chlortetracycline in the Diet of Turkey Poults Artificially-Infected with Salmonella typhimurium

1976 ◽  
Vol 55 (6) ◽  
pp. 2176-2189 ◽  
Author(s):  
S.C. Nivas ◽  
M.D. York ◽  
B.S. Pomeroy
1957 ◽  
Vol 36 (1) ◽  
pp. 124-128 ◽  
Author(s):  
T.M. Ferguson ◽  
H.P. Vaught ◽  
L.D. Matterson ◽  
B.L. Reid ◽  
J.R. Couch

2019 ◽  
Vol 49 (2) ◽  
pp. 235
Author(s):  
S Rezaei ◽  
W.L. Chen ◽  
S.C.L. Candyrine ◽  
R.Q. Foo ◽  
M.F. Jahromi ◽  
...  

2008 ◽  
Vol 25 (No. 4) ◽  
pp. 202-207 ◽  
Author(s):  
N. Karagözlü ◽  
C. Karagözlü ◽  
B. Ergönül

In this research, the growth and survival of <i>E. coli</i> O157:H7, <i>Salmonella typhimurium</i> and <i>Staphylococcus aureus</i> were investigated during kefir fermentation. Two different levels of inoculation of the strains were conducted; the levels of 102 CFU/ml (EC-1, SA-1 and S-1) and 103 CFU/ml (EC-2, SA-2 and S-2). At 0, 2, 6, 12, and 24 hours of kefir fermentation at 23 ± 1°C, samples were taken and the counts of <i>E. coli</i> O157:H7, <i>S. typhimurium</i>, and <i>S. aureus</i> were determined. EC-1 grew from 2.29 ± 0.02 log CFU/ml to 4.13 ± 0.18 log CFU/ml whereas EC-2 grew from 3.22 ± 0.04 log CFU/ml to 6.78 ± 0.99 log CFU/ml. Both S-1 and S-2 viable populations grew during the fermentation period, where sample S-1 grew from 2.37 ± 0.20 log CFU/ml to 4.64 ± 0.67 log CFU/ml and sample S-2 grew from 3.52 ± 0.07 log CFU/ml to 5.60 ± 0.10 log CFU/ml. SA-2 strains grew from 3.06 log CFU/ml to 3.64 log CFU/ml, SA-1 strains grew from 2.28 log CFU/ml to 2.66 log CFU/ml. According to the findings, <i>E. coli</i> O157:H7, <i>S. typhimurium</i>, and <i>S. aureus</i> can survive in kefir during fermentation.


Animals ◽  
2020 ◽  
Vol 10 (10) ◽  
pp. 1849
Author(s):  
Arantxa Morales-Mena ◽  
Sergio Martínez-González ◽  
Kyle D. Teague ◽  
Lucas E. Graham ◽  
Roberto Señas-Cuesta ◽  
...  

This study’s objective was to evaluate the effect of the fermented soybean meal (FSBM) on Salmonella typhimurium (ST) to turkey poults using two models of infection. In the prophylactic model, one-day-old turkeys were randomly allocated to one of four different groups (n = 30 turkeys/group): (1) Control group, (2) FSBM group, (3) Control group challenged with ST (Control + ST), and (4) FSBM group challenged with ST (FSBM + ST). On day 9 of age, all poults were orally challenged with 106 colony forming units (CFU) ST and 24 h post-inoculation, intestinal samples were collected to determine ST recovery and morphometric analysis. Blood samples were collected to evaluate serum fluorescein isothiocyanate-dextran (FITC-d). In the therapeutic model, a similar experimental design was used, but turkeys were orally gavaged 104 CFU ST on day 1, and samples were collected at day 7. FSBM improved performance and reduced leaky gut in both experimental infective models. In the prophylactic model, FSBB induced morphology changes in the mucosa. Although the strains (Lactobacillus salivarius and Bacillus licheniformis) used for the fermentation process showed in vitro activity against ST, no significant effect was observed in vivo. The fermentation with different beneficial bacteria and different inclusion rates of FSBM requires further investigation.


Sign in / Sign up

Export Citation Format

Share Document